Johnson & Johnson

Market Cap (Mar-08-2026)

579.340 Billion USD

World Rank (Jan-05-2024)

21

Market Cap (Jan-05-2024)

387.499 Billion USD

World Rank (Jul-30-2023)

15

Market Cap (Jul-30-2023)

453.430 Billion USD

World Rank (Jan-07-2022)

14

Market Cap (Jan-07-2022)

457.940 Billion USD

World Rank (Jan-01-2021)

14

Market Cap (Jan-01-2021)

414.310 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 12

Headquarters Country

USA

Nasdaq / NYSE Code

JNJ

CEO

Joaquin Duato

Chairman

William C. Weldon

Founders

James Wood Johnson

Robert Wood Johnson I

Edward Mead Johnson

Employee Count

155,800

Employee Count as of Date

As on Jan-2023

Headquarters City/State

New Jersey

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

94,193 Million USD

Annual Operating Income in USD

25,515 Million USD

Annual Net Income in USD

26,804 Million USD

Annual Results for Period Ending

Dec-2025 ending year

Total Assets in USD

199,210 Million USD

Total Liabilities in USD

117,666 Million USD

Total Equity in USD

81,544 Million USD

Balance Sheet for Period Ending

Dec-2025 ending year

Business Sector

Healthcare

Medical Equipment / Instruments

Pharmaceutical

FMCG

Biotechnology

Company Website

Johnson & Johnson - Top Consumer Goods, Pharmaceuticals, Medical Devices Company

Wikipedia

Yahoo

Yahoo @ NYSE

Facebook

Company Profile

Johnson & Johnson manufactures Consumer Goods, Medical Devices and Equipment and Pharmaceutical Products. As on 2023, Johnson & Johnson has 155,800 employees across 60 countries. Headquarters is in USA.

As on December-2021, The Company’s subsidiaries operate 85 manufacturing facilities occupying approximately 15.0 million square feet of floor space for managing consumer goods, medical devices and pharmaceutical business segments.

Facts About Company

Johnson & Johnson annual revenue generated for period ending Dec-2023 was 85.15 Billion USD and annual net income was 35.15 Billion USD
Johnson & Johnson annual revenue generated for period ending Dec-2022 was 94.94 Billion USD and annual net income was 17.94 Billion USD.
Johnson & Johnson annual revenue generated for period ending Dec-2021 was 93.77 Billion USD and annual net income was 20.87 Billion USD.

Johnson & Johnson annual sales by segment wise for period ending in Dec-2022:

Consumer Health segment annual sales in 2022 was 14,953 Million USD.
Pharmaceutical segment annual sales in 2022 was 52,563 Million USD.
MedTech segment annual sales in 2022 was 27,427 Million USD.

Annual Results Summary

Johnson & Johnson - Annual Results Summary - in Million USD:

Fiscal Year	Fiscal Year End	Total Annual Revenue (USD mm)	Gross Profit (USD mm)	*Operating Profit (USD mm)**	Net Income (USD mm)
2025	2025-12-28	94,193	63,937	25,287	26,804
2024	2024-12-29	88,821	61,350	20,804	14,066
2023	2023-12-31	85,159	58,606	21,207	35,153
2022	2023-01-01	94,943	63,854	23,382	17,941
2021	2022-01-02	93,775	63,920	23,395	20,878
2020	2021-01-03	82,584	54,157	19,486	14,714
2019	2019-12-29	82,059	54,503	19,814	15,119
2018	2018-12-30	81,581	54,490	19,798	15,297
2017	2017-12-31	76,450	51,011	18,180	1,300
2016	2017-01-01	71,890	50,205	20,371	16,540

Balance Sheet Summary

Johnson and Johnson - Balance Sheet Summary - in Million USD:

Fiscal Year	Total Assets (USD million)	Total Liabilities (USD million)	Total Equity (USD million)
2025	199,210	117,666	81,544
2024	180,104	108,614	71,490
2023	167,558	98,784	68,774
2022	187,378	110,574	76,804
2021	182,018	107,995	74,023
2020	174,894	111,616	63,278
2019	157,728	102,702	55,026
2018	152,954	93,202	59,752
2017	157,303	97,143	60,160
2016	141,208	70,790	70,418

Founded Year

1886

Institutional Investors

Top 30 Institutional Investors in JOHNSON & JOHNSON as on MAR-31-2023

RANK	Institutional Investors	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	3/31/2023	246,930,357	103,736	0.04%	$42,763,399
2	BLACKROCK INC.	3/31/2023	201,491,567	2,688,798	1.35%	$34,894,310
3	STATE STREET CORP	3/31/2023	140,265,123	-1,819,255	-1.28%	$24,291,114
4	GEODE CAPITAL MANAGEMENT, LLC	3/31/2023	48,707,500	748,917	1.56%	$8,435,165
5	MORGAN STANLEY	3/31/2023	40,003,520	-2,221,001	-5.26%	$6,927,810
6	NORTHERN TRUST CORP	3/31/2023	33,474,647	-282,321	-0.84%	$5,797,139
7	STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	3/31/2023	31,675,492	0	0%	$5,485,562
8	BANK OF AMERICA CORP /DE/	3/31/2023	30,352,766	-758,382	-2.44%	$5,256,492
9	PRICE T ROWE ASSOCIATES INC /MD/	3/31/2023	26,833,801	-2,443,973	-8.35%	$4,647,078
10	NORGES BANK	12/31/2022	26,093,398	1,609,376	6.57%	$4,518,855
11	JPMORGAN CHASE & CO	3/31/2023	25,723,516	-5,938,961	-18.76%	$4,454,799
12	WELLINGTON MANAGEMENT GROUP LLP	3/31/2023	25,386,775	-1,474,344	-5.49%	$4,396,482
13	BANK OF NEW YORK MELLON CORP	6/30/2023	23,470,152	-676,685	-2.80%	$4,064,561
14	MASSACHUSETTS FINANCIAL SERVICES CO /MA/	3/31/2023	21,097,191	-48,566	-0.23%	$3,653,612
15	WELLS FARGO & COMPANY/MN	3/31/2023	20,184,884	136,017	0.68%	$3,495,618
16	LEGAL & GENERAL GROUP PLC	3/31/2023	18,735,910	325,520	1.77%	$3,244,685
17	FMR LLC	3/31/2023	17,747,706	-1,344,454	-7.04%	$3,073,548
18	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	3/31/2023	17,146,319	59,748	0.35%	$2,969,400
19	CAPITAL INTERNATIONAL INVESTORS	3/31/2023	17,101,685	-467,969	-2.66%	$2,961,670
20	DEUTSCHE BANK AG\	3/31/2023	15,251,191	13,025	0.09%	$2,641,201
21	AMERIPRISE FINANCIAL INC	3/31/2023	14,925,194	-2,544,534	-14.57%	$2,584,745
22	INVESCO LTD.	3/31/2023	13,901,658	1,282,831	10.17%	$2,407,489
23	ROYAL BANK OF CANADA	3/31/2023	13,371,002	-1,109,276	-7.66%	$2,315,590
24	FRANKLIN RESOURCES INC	3/31/2023	12,250,638	-89,988	-0.73%	$2,121,565
25	ROBERT WOOD JOHNSON FOUNDATION	3/31/2023	12,145,550	0	0%	$2,103,366
26	GOLDMAN SACHS GROUP INC	3/31/2023	11,506,763	-1,061,987	-8.45%	$1,992,741
27	BARCLAYS PLC	6/30/2023	11,287,765	4,059,112	56.15%	$1,954,815
28	UBS ASSET MANAGEMENT AMERICAS INC	3/31/2023	11,209,368	165,097	1.50%	$1,941,238
29	NUVEEN ASSET MANAGEMENT, LLC	3/31/2023	10,888,307	-31,613	-0.29%	$1,885,637
30	UBS GROUP AG	3/31/2023	10,806,220	-1,608,156	-12.95%	$1,871,421